Home › Spinal Cord Injuries › District of Columbia › Washington
Spinal Cord Injuries clinical trials in Washington, DC
4 studies for Spinal Cord Injuries are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
RecruitingObservational study
- Medstar National Rehabilitation Hospital, Washington D.C.
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
RecruitingEarly phase 1
- Medstar National Rehabilitation Hospital, Washington D.C.
Intravesical LGG VS Saline Bladder Wash RCT
RecruitingPhase 2
- MedStar National Rehabilitation Hospital, Washington D.C.
Spinal Cord Injury Registry - North American Clinical Trials Network
RecruitingObservational study
- Walter Reed National Military Medical Center, Bethesda · 7 mi away
About Spinal Cord Injuries
Spinal cord injuries disrupt signals between your brain and body. This can cause problems like weakness and paralysis. Read about treatment and rehab.
More about Spinal Cord Injuries on MedlinePlus
Spinal Cord Injuries trials in other cities
- Miami, FL15 studies
- Chicago, IL14 studies
- Houston, TX14 studies
- Newark, NJ13 studies
- Cleveland, OH12 studies
- Philadelphia, PA8 studies
- The Bronx, NY8 studies
- New York City, NY8 studies
- Minneapolis, MN7 studies
- Charleston, SC7 studies
- St. Louis, MO7 studies
- Jacksonville, FL6 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.